Scientific Computing World reports that Isogenica has launched a collaborative joint venture with Biolauncher and Cresset Biomolecular Discovery to develop an “end-to-end therapeutic discovery platform.” Under the terms of the collaboration, the parties will integrate their expertise in peptide library design, evolutionary screening, next-generation sequencing, structural analytics, and molecular-field-based computational chemistry to identify active compounds […]